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Abstract
Introduction
The Affordable Care Act (ACA) expanded the coverage of Medicaid to include entire popula-
tion with income below 138% of federal poverty line. It remains unclear whether this policy
change has improved access to and utilization of health care, particularly use of mammogra-
phy and Pap tests among poor women.
Methods
We used a difference-in-difference (DID) design to estimate the impact of Medicaid expan-
sion on mammography and Pap tests utilization among low-income women. Expansion
states are the treatment group and non-expansion states are the control group. The years
2012–13 are the pre-expansion period and 2015–16 are the post-expansion period for the
purpose of estimating the DID parameters.
Results
The difference-in-difference estimate show that likelihood of utilizing mammograms did not
change significantly among low-income women after the implementation of Medicaid expan-
sion (DID coefficient -0.0476 with t-statistics at -1.26), Pap test decreased (coefficient
-0.0615, t-statistics -2.76), and Medicaid enrollment has increased significantly among low-
income women living in expansion states (coefficient 0.0889 with t-value of 3.68).
Conclusion
Expansion of Medicaid was associated with increased Medicaid enrollment but did not yield
near-term improvement in use of mammography and Pap tests among low-income women.
Factors beyond health insurance coverage may be important in determining the likelihood of
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obtaining these screenings. Policy makers should try to identify other barriers to cancer
screenings among low-income women in the USA.
Introduction
Breast cancer is the most commonly diagnosed cancer among American women, and the sec-
ond most common cause of death from cancer besides lung cancer [1,2]. Cervical cancer inci-
dence rates declined by half between 1975 and 2014 due to the widespread uptake of the Pap
test, but declines have slowed down in recent years [1,2]. Evidence show that women who
appropriately screen for breast and cervical cancer are likely to receive more timely diagnosis
and treatment [3–10] and yet, rates of mammography and Pap test screenings remained sub-
optimal in the United States [11]. Low-income women utilize less screenings than middle or
high income women. In 2015, 54.9% of low-income women received mammography while
60% received Pap test [11]. Goals of Healthy People 2020 include increasing the proportion of
women who get mammograms to 81%, and Pap tests to 93%, based on the most recent guide-
lines [12]. There are several possible reasons for the suboptimal screening rates, among which
lack of health insurance coverage is considered an important one. There is evidence that health
insurance is associated with uptake of mammogram and Pap test use [13–17].
The Patient Protection and Affordable Care Act of 2010 (ACA) expanded the coverage of Med-
icaid to include the entire population aged 18–64 with income below 138% of the federal poverty
line [18]. Since uninsured adults were more likely to be low-income, Medicaid expansion has the
potential for improving access to health care among this poor segment of the population [19–21].
One important role of health insurance is reducing the cost of receiving preventive care and in
turn, reduce costly events from poorly or unmanaged chronic conditions. Under ACA, participa-
tion of States in Medicaid expansion became optional after a supreme court ruling in 2012 [22]
but many states decided to participate in Medicaid expansion immediately after the policy change
and by September 2015, majority of the states have expanded Medicaid. As of September 2018, 34
states have adopted Medicaid expansion, 3 states are considering expanding, and 14 states did not
expand. S1 Table lists the states with Medicaid expansion status as of September 2018 [23].
Previous evidence gave mixed results regarding the impact of Medicaid expansion on utili-
zation of mammography and Pap tests [24–29]. Expansion experiences from pre-ACA antici-
pated positive effect on screening rates [26–28], while post-ACA either did not find significant
impact [24,25] or found a favorable results when analyzing utilization in a community health
center [29]. In any case, these studies had a short follow-up time after the introduction of ACA
which perhaps made it difficult to detect significant change. Also, the individuals’ lack of
knowledge/awareness of preventive care benefits provided by the ACA [30] may explain the
limited impact of the coverage expansion on their use of these services.
Since no conclusive evidence is available, this study made an attempt to understand the
effect of Medicaid expansion on probability of obtaining screening tests like mammography
and Pap tests among low-income women. Since the study is using nationally representative
data set, the results would indicate the effects of policy change for the country as a whole.
Nationally representative data will also allow identification of factor affecting utilization rates.
Materials and methods
Data source
Data for this study was obtained from the Medical Expenditure Panel Survey—Household
Component MEPS-HC [31]. The MEPS is a set of large-scale surveys which collects data from
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a sample of families and individuals in selected communities across the United States, drawn
from a nationally representative subsample of households. The MEPS contains the data on
health care utilization, health insurance status, and coverage source that are required to answer
the research question of the study. The combined average response rate for the years 2012–
2016 was 50.7% [32]. The study was reviewed and approved by the Office of Research Compli-
ance, an administrative office that supports the University of South Carolina Institutional
Review Board (USC IRB). All data used was fully anonymized before it was accessed.
Sample
From the 2012–16 MEPS datasets, the sample extracted consists of nonelderly low-income
women living in the U.S. The sample size was 6,427 in expansion states (3,459 pre-ACA and
2,968 post-ACA) and 6,831 in non-expansion states (3,729 pre-ACA and 3,102 post-ACA).
Women living in states that already provided Medicaid or similar coverage to low-income
adults before ACA’s Medicaid expansion in 2014 were excluded from the analysis (District of
Columbia, Delaware, Massachusetts, New York, and Vermont). Women aged 65 years or
older were excluded because they are eligible for Medicare. Women belonging to low-income
households, as defined by the ACA, were selected for the analysis as this group is eligible for
participation in Medicaid after the policy change, if they were not enrolled in Medicaid at the
time of expansion. In accordance with screening guidelines, the mammography cohort will
include women aged 40–64 and the Pap test cohort will include women aged 21–64. Women
with concurrent or past diagnoses with breast or cervical cancer were excluded from the analy-
sis to focus on utilization of screening services for preventive or early diagnosis purposes.
Design
This study used a difference-in-difference (DID) design in a regression framework. This ana-
lytic design tests a comparison of the change in trends of outcomes before and after Medicaid
expansion across expansion states vs non-expansion states, controlling for other covariates rep-
resenting risk attitudes and preference structure. The treatment group includes women living in
Medicaid expansion states and control group includes women living in non-expansion states.
Only the states that expanded Medicaid between January 2014 and January 2016 were included
in the treatment group (S1 Table). The states that already provided Medicaid or similar coverage
to low-income adults before 2014 were excluded (District of Columbia, Delaware, Massachu-
setts, New York, and Vermont) (S1 Table). For estimating the DID parameters, pre-ACA period
is defined as the years 2012–13 and the post period is defined as the years 2015–16.
The following multivariate linear regression was estimated to find the effect of the policy
change on the outcome variables, the likelihood of receiving mammography and pap smears:
Yist ¼ b0 þ b1Treatment þ b2Post þ b3ðTreatment � PostÞ þ bxCovariatesþ ε
Where “Yist” represents outcome for individual “i” living in state “s” at time ‘t”. β0 is the
baseline average. The term “Treatment” is a dummy variable equal to 1 if the individual resides
in a treatment group (expansion state). β1 is the difference between the two groups pre-inter-
vention. The term “Post” is a dummy variable equal to 1 if the time is after the Medicaid
expansion. β2 is the time trend in control group. The term “Treatment�Post” is an interaction
term of intervention and time, β3 represents the difference-in-differences estimator capturing
the effect of Medicaid expansion. Covariates are added to the model to control for preference
structure and risk attitudes.
This regression model, in theory, will be able to indicate the effect of treatment if the inter-
vention and control groups are identical at the baseline or show similar pattern of change over
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the years. In the real world, the intervention and control groups in pre-intervention period are
never identical and therefore differences between the groups need to be explicitly considered
and incorporated in the analysis. The effect of program change can be estimated if the assump-
tion of similar pattern of changes over the years in pre-intervention years may be assumed in
post-intervention periods as well. This is known as the “parallel assumption” in DID analysis.
Since the parallel assumption must hold for an unbiased DID estimator, we can test the parallel
movements or trend in the outcomes prior to policy change in treatment and control groups
over a number of years. To assess the validity of this assumption, we regressed each outcome
for the years 2005 to 2013 on variables indicating years, state expansion status and an interac-
tion term of year and state expansion status. If the coefficient of the interaction term is not sta-
tistically different from zero, it implies that the rate of change of the dependent variables is not
different between the intervention and control areas confirming the parallel movement of the
outcome over the years prior to the implementation of the intervention.
Outcome
The outcomes for this study are the self-reported receipt of mammogram, Pap test, and Medic-
aid enrollment status. For the preventive services, respondents were asked “About how long
has it been since you had this mammogram/Pap test?” with possible responses being “within
past year,” “within past 2 years,” etc. In accordance with screening guidelines, a dummy vari-
able was created for mammogram utilization equal to 1 if the test was taken within 1 to 2 years,
and a dummy variable for pap test utilization equals to 1 if the test was taken within 1 to 3
years.
Covariates
We controlled for variables that we believe may modify the preference structure and risk atti-
tude of women in the sample. According to the Demand Theory, demand for health services is
a function of prices of the services, household income, preference structure, and risk-attitude.
We chose covariates that may modify the preference structure and risk attitude, making indi-
viduals more risk averse and therefore more likely to undergo screening tests. The covariates
chosen are: age, race, marital status, education, health insurance status, comorbidity, physical
activity, smoking status, and metropolitan area.
Statistical analysis
First, univariate analysis was done to produce baseline descriptive statistics of the low-income
women living in treatment (expansion states) and control groups (non-expansion states). Sec-
ond, we tested the parallel trends assumption across expansion and non-expansion states by
regressing each outcome for the years 2005 to 2013 on variables indicating years, state expan-
sion status and an interaction term of year and state expansion status. Third, a difference-in-
differences regression model was estimated by linear ordinary least squares. A linear model
was chosen to allow a direct interpretation of the coefficients and avoid interpretive issues
inherent to interaction terms in nonlinear models [33,34]. The key parameter of interest from
the DID model was the parameter associated with the interaction between treatment and time.
This parameter represents the estimated difference in outcome rates between pre- and post-
policy change, across states that were and were not affected by the policy change. Differences
were considered statistically significant if P-value of t-statistics <0.05. Finally, a sub-group
analyses was done using linear regression and univariate analysis to explain the effect of differ-
ent demographics, socioeconomics, and geographic determinants on screening use. All analy-
ses were carried out using STATA software version 14 (2015; Stata 14.0 Statistical Software,
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College Station, TX, USA). The analyses accounted for probability weighting in the MEPS
[35,36] to obtain national estimates of effects of the policy change.
Results
Table 1 shows the baseline characteristics of the nonelderly low-income women living in
expansion and non-expansion states. Majority of the low-income women were white in both
expansion and non-expansion states, however, more black women lived in non-expansion
states (37.38%) compared to expansion states (23.94%). In both treatment and control groups,
majority of low-income women did not have a college degree (Table 1). In expansion and
non-expansion states, majority of low-income women had public health insurance, however,
more women had public health insurance in expansion states (53.22%) as compared to non-
expansion states (41.67%). Majority of the low-income women lived in metropolitan areas in
both treatment and control groups (Table 1). Women in treatment and control groups had a
similar average age (37). Therefore, states deciding to expand Medicaid were different from
the states deciding not to expand in terms of percent of low income population not white, level
of coverage of public insurance program and percent of poor women living in metro areas.
Fig 1 shows trends in mammogram and Pap tests rates across expansion and non-expan-
sion state for the years 2005 to 2013. Results from the regression that tested the parallel
assumption of the time trend of outcome variable show that the slope of the trend functions
were similar for these two groups of states prior to the implementation of the ACA policy on
Medicaid expansion (S2 Table).
Results from the univariate analysis that examined screening rates among women living in
expansion states post-ACA by different sub-groups can be found in S3 Table. The results show
majority of low-income women who used mammograms and Pap tests were high-income
(76.20%, 85.73%) high-education attainment (72.93%, 83.88%), Black (73.61%, 87.91%), with
private insurance (74.20%, 84.13%), living in metropolitan areas (71.36%, 83.13%), and
reported having a usual source of care (74.52%, 83.92%), for mammograms and Pap tests
respectively.
Table 1. Baseline characteristics of low-income women aged 18–64, living in expansion and non-expansion states, pre-ACA (2012–13), MEPS dataset.
Characteristic Non-expansion states
N = 3,729
Expansion states
N = 3,459
P value
Age 37 (mean) 37 (mean) 0.0839
Race 0.000
White 57.39 67.07
Black 37.38 23.94
Other minorities 5.23 8.99
Education 0.000
Some school 34.51 38.90
High school 34.54 31.17
College 30.95 29.94
Health insurance 0.000
Private 18.10 16.48
Public 41.67 53.22
Uninsured 40.23 30.30
Metropolitan area 0.000
Metro 82.38 87.80
Non-metro 17.62 12.20
https://doi.org/10.1371/journal.pone.0214886.t001
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Fig 1. Trends in mammogram and Pap test uptakes in expansion and non-expansion states among low-income women, MEPS 2005–13.
https://doi.org/10.1371/journal.pone.0214886.g001
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Table 2 reports the results from the difference-in-difference adjusted regression model.
The DID estimates indicate that the probability of enrolling to Medicaid has increased signifi-
cantly among the low-income women after the implementation of Medicaid expansion (esti-
mated coefficient 0.0889 with t-value 3.68). The DID estimates indicate that for the Medicaid
expansion states the probability of utilizing mammograms did not change significantly (esti-
mated coefficient -0.0476 with t-value -1.26) while for the Pap tests the probability of utilizing
the test has decreased significantly among low-income women after the implementation of
Medicaid expansion compared to non-expansion states (estimated coefficient -0.0615, t-value
-2.76).
Table 3 shows the results on the likelihood of receiving mammograms and Pap tests among
low-income women using a number of possible determinants of utilization of the screening
tests. The sub-group analysis shows that poor women with higher age were more likely to
receive mammograms (estimated coefficient 0.0102, t-value 4.16) and less likely to receive Pap
tests (estimated coefficient -0.174, t-value -5.08). Black women were more likely to receive
mammograms (estimated coefficient 0.0812, t-value 3.87) and Pap tests (estimated coefficient
0.0686, t-value 5.75) as compared to white women. The table also indicates that women from
other minority population groups were less likely to receive Pap tests as compared to white
women (estimated coefficient -0.0646, t-value -2.90). Women with a college degree were more
likely to receive mammograms (estimated coefficient 0.0605, t-value 2.56) than those who had
less than high school education. Women who were divorced were less likely to receive mam-
mograms (coefficient -0.0875, t-value -3.47) and Pap tests (coefficient -0.0385, t-value -2.00)
compared to married women. Women with public health insurance or no insurance (unin-
sured) were less likely than those with private insurance to receive mammograms (estimated
coefficients -0.0654 and -0.250). No statistically significant difference was detected for Pap test
use between women with public and private insurance (estimated coefficient -0.00391, t-value
-0.26) although uninsured women were less likely to receive and Pap tests (estimated coeffi-
cient -0.110, t-value -6.61).
Women living in non-metropolitan areas were less likely than those in metropolitan areas
to receive Pap tests (estimated coefficient -0.0615, t-value -3.41) but no difference was detected
for mammogram use (estimated coefficient -0.0489, t-value -1.62). Women who reported not
having a usual source of care were less likely to receive mammograms (estimated coefficient
-0.141, t-value -4.03) and Pap tests (estimated coefficient -0.0562, t-value -3.02) compared to
those who have a usual source of care. Non-smokers were more likely to receive mammograms
Table 2. Results from the difference-in-differences adjusted regression model, nonelderly low-income women (2012–16), MEPS dataset.
Outcome Expansion states Non-expansion states Difference-in-differences
Pre-ACA rate Post-ACA rate Pre-ACA rate Post-ACA rate
Mammogram 62.66% 64.69% 58.87% 61.77% -0.0476
(-1.26)
Pap tests 81.90% 80.19% 78.80% 79.36% -0.0615��
(-2.76)
Medicaid enrollment 38.10% 52.31% 21.12% 25.03% 0.0889���
(3.68)
t statistics in parentheses
� p<0.05
�� p<0.01
��� p<0.001
https://doi.org/10.1371/journal.pone.0214886.t002
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(estimated coefficient 0.0706, t-value 3.15) and Pap tests (estimated coefficient 0.0446, t-value
3.30) as compared to smokers. Women with two or more chronic diseases were more likely to
receive mammograms (estimated coefficient 0.133, t-value 5.22) but no differences were
detected for Pap test use (estimated coefficient 0.0251, t-value 1.58).
Table 3. Likelihoods of receiving mammograms and Pap tests using a number of determinants, results from
adjusted linear regression model (2012–16), MEPS dataset.
Determinants Mammogram Pap test
Age (continuous) 0.0102���
(4.16)
0.000137
(0.11)
21–39 NA Reference
group
40–49 Reference
group
-0.0789���
(-3.59)
50–64 -0.00818
(-0.23)
-0.174���
(-5.08)
Black(Reference group: White) 0.0812���
(3.87)
0.0686���
(5.75)
Other minorities(Reference group: White) -0.0588
(-1.59)
-0.0646��
(-2.90)
High school(Reference group: Some school) 0.0419
(1.82)
-0.00437
(-0.33)
College(Reference group: Some school) 0.0605�
(2.56)
-0.0120
(-0.85)
Widowed(Reference group: Married) -0.103�
(-2.56)
-0.0883�
(-2.47)
Divorced(Reference group: Married) -0.0875���
(-3.47)
-0.0385�
(-2.00)
Separated from spouse(Reference group: Married) -0.0799�
(-2.37)
-0.00593
(-0.27)
Never Married(Reference group: Married) -0.0749��
(-2.86)
-0.0277�
(-2.03)
Public insurance(Reference group: Private insurance) -0.0654�
(-2.55)
-0.00391
(-0.26)
Uninsured(Reference group: Private insurance) -0.250���
(-8.97)
-0.110���
(-6.61)
Non-metropolitan area(Reference group: Metropolitan area) -0.0489
(-1.62)
-0.0615���
(-3.41)
Usual source of care not available(Reference group: Usual source of care not
available)
-0.141���
(-4.03)
-0.0562��
(-3.02)
Do not exercise regularly(Reference group: Exercise regularly) -0.00171
(-0.09)
-0.0102
(-0.92)
Non-smoker(Reference group: Smoker) 0.0706��
(3.15)
0.0446���
(3.30)
1 chronic disease(Reference group: No chronic disease) 0.0479
(1.68)
0.0223
(1.63)
+2 chronic diseases(Reference group: No chronic disease) 0.133���
(5.22)
0.0251
(1.58)
t statistics in parentheses
� p<0.05
�� p<0.01
��� p<0.001
https://doi.org/10.1371/journal.pone.0214886.t003
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Discussion
The affordable care act (ACA) expanded Medicaid eligibility coverage to the entire low-
income population in order to improve access and utilization among this disadvantage section
of the population. In the years before the ACA, rates of mammograms and Pap tests showed
declining trends among women and more so among poor women [11]. This study examined
the impact of expanding health coverage through Medicaid on the rates of mammograms and
Pap tests among poor women. The difference-in-difference (DID) estimates indicate that
Medicaid enrollment has increased significantly among low-income women after the imple-
mentation of the Medicaid expansion (Table 2). This is a proximate measure of success of
ACA in terms of providing coverage to poor women through Medicaid. Other studies also
found increased Medicaid enrollment in expansion states compared to non-expansion states
[37]. However, the increase in Medicaid enrollment among low-income women did not trans-
late into increased rates of mammograms or Pap test utilization compared to poor women in
non-expansion states. Other studies also found little impact of Medicaid expansion on mam-
mography and Pap tests rates [37–39].
Although the difference-in-differences estimate did not show increase in mammograms
and Pap tests rates, low-income women living in expansion states used more screenings than
their counterparts in non-expansion states (Table 2). Historically, mortality rates of breast and
cervical cancer were lower in the states that elected to expand Medicaid compared to those
who elected not to expand [40]. We compared cancer burden in expansion vs non-expansion
states in pre and post-ACA using data from the National Cancer Institute (NCI) and found
that women in expansion states had lower mortality rates compared to women in non-expan-
sion states (breast cancer: 20.13 vs 20.50; and cervical cancer: 1.97 vs 2.41) per 100,000 resident
[40]. A previous study found that Southeastern states without Medicaid expansion tended to
have higher cancer and lower screening rates and therefore disparities in cancer screening that
already disfavor states with high cancer rates may widen in states that have chosen not to
expand Medicaid [41].
A number of possible explanations can be advanced for this lack of improvements in mam-
mograms and Pap tests rates among the low-income women despite gaining insurance cover-
age through Medicaid. First, poor knowledge/awareness about the availability of preventive
benefits through ACA may result in low access to these services. There is evidence showing
that newly insured individuals are not aware of the preventive services benefits of the ACA
and thus do not use them [30]. Another study found that only 36.4% of adults reported know-
ing that the ACA requires coverage of certain preventive services without cost sharing [42].
Therefore, strategies aimed at improving public awareness about the availability of preventive
services may be a vital tool in improving screening rates.
Second, in the U.S. health system, acute care takes priority over prevention. Studies have
found that time constraints limit the ability of primary physicians to comply with preventive
services recommendations [43]. A study has found that in states with higher Medicaid pay-
ments for office visits, Medicaid beneficiaries were more likely to be screened for breast and
cervical cancer [44]. This indicate that increasing screenings among vulnerable population
may be achieved through enhanced Medicaid reimbursements for physician consultations.
Third, our analysis show that low-income women with private insurance were more likely
to receive mammograms than those with public insurance (Table 3). Also, in expansion states,
the proportion of low-income women with private insurance used more mammograms and
Pap tests than those with public insurance (S3 Table). Another study found that women with
employer-based insurance/Medicare were more likely to get breast and cervical cancer screen-
ings [45]. According to a survey conducted by the National Center for Health Statistics, only
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two out of three primary care physicians surveyed in 2011 were willing to accept new Medicaid
patients [46]. Our analysis showed that women who reported having a usual source of care
were more likely to receive mammograms and Pap tests than those without a usual source of
care (Table 3). In expansion states, the proportion of low-income women who have a usual
source of care used more mammograms and Pap tests than their counterparts in non-expan-
sion states (S3 Table). Therefore, insurance-type and having a usual source of care appear to be
more important in improving access to care and receiving these screenings.
A number of studies did find that Medicaid expansion was effective in improving utilization
rates of certain preventive services such as glucose testing, cholesterol testing, and annual
check-up, but not for cancer screenings [24,47]. The U.S. Preventive Services Task Force
(USPSTF) guidelines for mammograms and Pap tests were updated around the time ACA was
being implemented. The guidelines for mammograms were updated in 2009 to recommend
mammograms for women aged 50–75 years every 2 years from the previous guidelines that
recommended screening every 1–2 years for women aged 40 or older [48]. The guidelines for
cervical cancer screenings was updated in 2012 to recommend the Pap test for women aged
21–65 every three years from the previous guidelines that recommended screening annually
for women who are sexually active. This may explain the overall decline in cancer screenings
in recent years. However, the effect of revised guidelines should be universal applicable to both
expansion and non-expansion states and therefore may not explain the lack of effect on mam-
mograms and Pap tests in expansion states in our difference-in-difference design.
It is also possible that the results from the difference-in-difference model are biased or
washed-out because of the possibility that a significant number of poor women received
screenings through other national programs such as the National Breast and Cervical Cancer
Early Detection Program (NBCCEDP) through the Centers for Disease Control and Preven-
tion (CDC). The program was established in 1990 to provide free and/or reduced cost mam-
mograms and Pap tests to women with limited incomes and those who lack health insurance.
Although number of women receiving those services through the NBCCEDP has decreased in
2015–16 compared to 2013 [49], low-income women still benefit from this program which
may have negated the impact of ACA on mammograms and Pap tests rates in our difference-
differences analysis. Between 2012 and 2017 the NBCCEDP program provided 740,108 Pap
tests and 902,751 mammograms to low-income women [49]. During 2012 to 2017, this pro-
gram provided 441,206 Pap tests (452 screenings per 100,000 woman) and 498,659 mammo-
grams (511 screenings per 100,000 woman) in expansion states. During this same period, 398
and 573 per 100,000 woman received Pap tests and mammography respectively in non-expan-
sion states through this program [49]. Mammograms provided to women in non-expansion
states was about 12% higher than the rate in expansion states and the opposite is true for Pap
tests (12% lower in non-expansion states). Such differences in coverage rates of an external
program can potentially bias the estimation of the effect of ACA on mammograms and Pap
tests uptakes.
Our empirical analysis showed that screenings occurred at much higher rates among the
high-income high-educated women while the low-income women had the lowest utilization
rates (S3 Table). Before the ACA, a study found that the low-income women were less likely to
receive possibly lifesaving recommended cancer screenings [50]. A post-ACA study examined
the impact of Medicaid expansion on disparities in cancer screenings and found that large
gaps remain in access, particularly for low-income adults [51]. Our analysis showed that dis-
parities in terms of using mammograms and Pap tests remained and may have actually become
worse. This possibly implies that other factors beyond insurance coverage (in this case, pro-
vided through Medicaid) should be examined in order to better understand the reasons for the
persistence of socioeconomic disparities.
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Finally, our sub-group analyses helped shed light on the likelihood of receiving mammo-
grams and Pap tests among low-income women using a number of possible determinants of
utilization. As women get older they are more likely to receive mammograms and less likely to
receive pap tests (Table 3). This is expected as evidence suggests that the benefits from mam-
mograms are more evident for older women while benefits from Pap tests are more evident for
younger women [52,53]. Low-income women living in metropolitan areas were more likely to
receive mammograms and Pap tests in both expansion and non-expansion states (Table 3).
This is expected as access to care is better in metropolitan areas than in non-metro areas. Black
women were more likely than white women to receive a Pap test (Table 3) and in expansion
states, the proportion of black women receiving mammograms and Pap tests were higher than
white women (S3 Table). African American women in the U.S. are more likely to be diagnosed
and die from breast and cervical cancer than white women, which may explain the increased
use of the screenings [54].
Limitations
We acknowledge some important limitations of this study. First, information about outcomes
relied on self-reported survey responses which might be subject to recall error. However, the
MEPS follow up with health providers to reduce the reporting bias but some errors may still
remain, especially for procedures and tests requiring longer recall time frame. Second, the data
used in the analysis are cross-sectional and comparison of cross-sectional data at different
years is not same as observing changes in the outcomes for a cohort with the implementation
of ACA. The study design made an attempt to tease-out the effect of policy changes through
DID and in most cases DID approach can identify the effect of policy change even when the
starting characteristics of the control and intervention groups are significantly different.
Third, this study examined the initial 3-year period after the ACA Medicaid expansion provi-
sion and a longer time frame may be needed to be able to see the effects of policy changes on
outcomes. Finally, there were changes in the USPSTF guidelines for breast cancer and cervical
screening that occurred around the same time as the ACA provisions but it should not affect
the results of DID. One of the important sources of bias that could not be corrected for in the
empirical analysis is the provision of these screenings to poor women by a national program
free of charge. If this national program in post-policy change years provided more emphasis
on offering screenings in non-expansion states, it can potentially offset any positive effects of
Medicaid expansion in DID modeling. In any case, this lack of relative improvements in can-
cer screenings in the Medicaid expansion states (compared to non-expansion states) is per-
plexing and would require supplementing the national data with the effects of alternative
programs and other structural differences between these two groups of states.
Conclusion
Our study shows that expansion of Medicaid under the ACA was associated with increased
Medicaid enrollment but did not yield near-term improvements in the use of mammography
and Pap tests among low-income women. Although the difference-in-differences did not show
improvements in mammograms and Pap tests due to Medicaid expansion under ACA, low-
income women living in expansion states used higher level of screenings than their counter-
parts in non-expansion states. Since Medicaid expansion did not affect these screening tests,
policy makers need to examine other factors that may act as barriers in improving access and
utilization. Some possible explanations for this lack of impact of the Medicaid expansion on
mammograms and Pap tests are presented in the discussion section but we have no concrete
evidence to conclusively say which factors have affected access to screening tests adversely in
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the expansion states compared to non-expansion states. It is also possible that a longer time-
frame will be needed for a change to be manifested itself rather than the three-year time frame
used here. Future research on provider availability and characteristics, insurance types, and
geographical variations is warranted for a better understanding of the use of cancer screening
procedures by the poor women in the USA.
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